The Home Health & Hospice sector had a very slow year in 2015, with just 47 deals made public. Deal making activity has picked up quite a bit in 2016, with 12 deals in the first two months and five more in the first three weeks of March.

The only deal to report a price was the $84 million acquisition of Genesis Healthcare‘s (NYSE: GEN) home health and hospice business, by Compassus. Genesis is selling the majority of its home health and hospice operations, which are located in California, Idaho, Montana and New Mexico. Privately-held Compassus is a nationwide network of community-based post-acute care services primarily focused on hospice, palliative and home health care.

In other deal announcements, LHC Group (NASDAQ: LHCG) acquired Hearlite Hospice from its parent company, Hospice of America, Inc.  Heartlite has four locations, two in the Certificate of Need state of Alabama and two in Georgia. PromptCare, which provides specialty respiratory products and infusion therapy services, acquired Boston Home Infusion. Despite its name, Boston Home Infusion serves patients in Connecticut, Massachusetts, New Hampshire and Rhode Island.

All is not rosy in the sector, however. American Hospice Management Holdings filed for bankruptcy protection on March 20, after unsuccessfully searching for a buyer since March 2013. The financial troubles began when the company agreed to pay $12 million to resolve allegations of false claims to Medicare for ineligible hospice services.

The company now has until April 30 to sell its business. Hospice Partners of America has made a stalking horse bid to buy American Hospice’s operations in Virginia and Texas. That would leave the comapny with operations in Arizona, Florida, Georgia, New Jersey and Oklahoma.